It’s widely accepted that SaaS has permanently changed software sales. Enterprise software sales once meant…
Portfolio
One thing that we investors always look for in entrepreneurs is deep domain knowledge paired with an extreme passion for the product. And it is hard to find somebody more knowledgeable and passionate about fashion jewelry than Chantel Waterbury, the CEO and founder of Chloe & Isabel. Chantel has worked more than a decade for […]
It’s widely accepted that SaaS has permanently changed software sales. Enterprise software sales once meant…
It’s the age-old debate among start-up circles: which is more important to the success of…
One thing that we investors always look for in entrepreneurs is deep domain knowledge paired with an extreme passion for the product. And it is hard to find somebody more knowledgeable and passionate about fashion jewelry than Chantel Waterbury, the CEO and founder of Chloe & Isabel. Chantel has worked more than a decade for brands like Cartier, Tiffany and Co., and Van Cleef and Arpels and has developed jewelry for almost every major retailer in the United States – talk about deep, deep domain knowledge. Her start-up, Chloe & Isabel, is set to revamp the direct sales industry in the fashion jewelry space (and $100+ billion industry worldwide) through a direct sales platform that provides sellers with personalized store fronts and the ability to make data driven recommendations.
It is a big opportunity and I am very excited to be part of it – looking forward to working again with First Round Capital, one of the lead investor in the Chloe & Isabel financing, and – most importantly – Chantel and her team!
P.S.: If you live in NYC and would like to get a chance to join Chloe & Isabel’s launch party this week, here is your chance.
Health / Biology, Portfolio, Version One
Shifting healthcare systems from reactive to proactive care is critical – the best outcomes occur when people can take action early, before a condition becomes a diagnosis. That’s why we are excited to announce that we have led a $2.5m pre-seed round for NiaHealth and are thrilled that they are coming out of stealth and […]
We are continually refining our thesis on healthcare, from looking at clinical-grade at-home diagnostics to biotech and…
Over the past year, some of the most interesting and intellectually-stimulating pitches we heard have…